Cystic Fibrosis Clinical Trial
Official title:
The iStep Study: Development and Validation of an Incremental Exercise Step Test for Children With Cystic Fibrosis
The progression of lung disease in cystic fibrosis (CF) results inevitably in a reduction in
exercise capacity. The assessment of fitness and exercise capacity in CF is an important
measure of the impact of the disease process, particularly if it is repeated over time. With
recent advances in clinical management, CF lung disease in children can be relatively mild
and exercise tolerance good. The currently available field tests e.g. 3 minute step test,
are often completed too easily. These tests provide limited information relating to maximal
exercise performance. By contrast, the maximal CardioPulmonary Exercise Test (CPET), a
progressive, incremental, gold standard exercise test with breath by breath analysis of
expired gas, has proved to be a valuable means of assessing exercise response in patients
with CF. Its only limitation is the requirement for specialist laboratory facilities,
equipment and staff.
A new field test for evaluating exercise capacity in children is needed. This should be
portable, easy to administer and simple to perform by young children, while providing a
higher intensity of exercise which correlates with day to day activity patterns of children,
and clinically relevant information in the short term and longitudinally. This test needs to
be a good surrogate measure of exercise capacity when formal CPET is unable to be
undertaken. By providing accurate and useful information the results can be used to
prescribe and train individuals with CF safely and effectively and can also be used in the
short and long term for guidance of the medical management of these complex patients.
The aim of this study is to develop and validate the use of a new incremental step test to
assess exercise tolerance/capacity in children with CF, compare this with the gold standard
CPET and to provide normative healthy control comparison data The main objectives of the
study are
1. To develop an incremental step test to assess exercise tolerance / capacity in children
with CF.
2. To compare the incremental step test with the gold standard CPET
3. To assess the level of exercise response produced by the incremental step test
4. To assess the correlation between independent variables of lung function measurements,
age, weight and height with VO2peak and other exercise test outcomes
5. To assess the repeatability and evaluate the normal variability of the new incremental
step test
6. To provide healthy control normative data for comparison
n/a
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
| Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
| Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
| Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
| Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
| Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
| Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
| Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
| Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
| Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
| Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
| Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
| Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
| Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
| Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
| Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
| Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
| Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |